» Articles » PMID: 35864539

The Mitochondrial Unfolded Protein Response (UPR): Shielding Against Toxicity to Mitochondria in Cancer

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2022 Jul 21
PMID 35864539
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are essential for tumor growth and progression. However, the heavy demand for mitochondrial activity in cancer leads to increased production of mitochondrial reactive oxygen species (mtROS), accumulation of mutations in mitochondrial DNA, and development of mitochondrial dysfunction. If left unchecked, excessive mtROS can damage and unfold proteins in the mitochondria to an extent that becomes lethal to the tumor. Cellular systems have evolved to combat mtROS and alleviate mitochondrial stress through a quality control mechanism called the mitochondrial unfolded protein response (UPR). The UPR system is composed of chaperones and proteases, which promote protein folding or eliminate mitochondrial proteins damaged by mtROS, respectively. UPR is conserved and activated in cancer in response to mitochondrial stress to maintain mitochondrial integrity and support tumor growth. In this review, we discuss how mitochondria become dysfunctional in cancer and highlight the tumor-promoting functions of key components of the UPR.

Citing Articles

Micheliolide attenuates sepsis-induced acute lung injury by suppressing mitochondrial oxidative stress and PFKFB3-driven glycolysis.

Li W, Li Y, Xiao L, Xie Z, Peng J, Huang W J Transl Med. 2025; 23(1):181.

PMID: 39953547 PMC: 11829335. DOI: 10.1186/s12967-024-05906-0.


Exploiting Mitochondria by Triggering a Faulty Unfolded Protein Response Leads to Effective Cardioprotection.

Shen Y, Gao X, Xiang Y, Zhou H, Zhu H, Wu Q Int J Med Sci. 2025; 22(1):188-196.

PMID: 39744160 PMC: 11659839. DOI: 10.7150/ijms.100523.


Integrated bioinformatics and machine learning algorithms reveal the unfolded protein response pathways and immune infiltration in acute myocardial infarction.

Bai Y, Niu Z, Yang Z, Sun Y, Yan W, Wu A J Thorac Dis. 2024; 16(10):6496-6515.

PMID: 39552895 PMC: 11565340. DOI: 10.21037/jtd-24-622.


Exploring paraptosis as a therapeutic approach in cancer treatment.

Chang L, Chiang S, Chen S, Hung M J Biomed Sci. 2024; 31(1):101.

PMID: 39497143 PMC: 11533606. DOI: 10.1186/s12929-024-01089-4.


A Review of Advances in Mitochondrial Research in Cancer.

Li Z, Zhang W, Guo S, Qi G, Huang J, Gao J Cancer Control. 2024; 31:10732748241299072.

PMID: 39487853 PMC: 11531673. DOI: 10.1177/10732748241299072.


References
1.
Schmidt O, Pfanner N, Meisinger C . Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol. 2010; 11(9):655-67. DOI: 10.1038/nrm2959. View

2.
Chandel N, Maltepe E, GOLDWASSER E, Mathieu C, Simon M, Schumacker P . Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998; 95(20):11715-20. PMC: 21706. DOI: 10.1073/pnas.95.20.11715. View

3.
Park S, Shin J, Jeong J, Song J, Jo Y, Kim E . Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction. J Biol Chem. 2013; 289(4):2195-204. PMC: 3900965. DOI: 10.1074/jbc.M113.492587. View

4.
Kong X, Meng W, Zhou Z, Li Y, Zhou B, Wang R . Overexpression of activating transcription factor 5 in human rectal cancer. Exp Ther Med. 2012; 2(5):827-831. PMC: 3440731. DOI: 10.3892/etm.2011.295. View

5.
Ishihara S, Yasuda M, Ishizu A, Ishikawa M, Shirato H, Haga H . Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget. 2015; 6(7):4602-14. PMC: 4467102. DOI: 10.18632/oncotarget.2912. View